A knockout corporate earnings season for the US stockmarket
First-quarter corporate earnings in the US beat analysts’ forecasts by a mammoth 30%.
USA Inc is vastly exceeding expectations. First-quarter earnings reported as of last Friday had beaten analysts’ forecasts by a mammoth 30%; usually “earnings beats” are about 3%-6%, says Bob Pisani for CNBC. The unprecedented uncertainty triggered by the pandemic caused many blue-chip firms to withdraw their guidance last year. That prompted the analysts who study these firms to make very conservative forecasts for the earnings outlook, which were widely thought to be too pessimistic. Most people expected this quarter’s earnings to be good, “but this is really good”.
US stockmarket valuations are historically high on a cyclically adjusted price/earnings ratio (Cape) of 34.6, according to Mebane Faber of Cambria Investment Management. Strong earnings are one way of bringing those valuations down to a more reasonable level. Bank earnings have been especially impressive, says The Economist. JPMorgan Chase reported record revenue in the first three months of the year. Profits have tripled in a year at Citigroup and doubled at Bank of America. For the first time since 2008 banks are reporting returns on equity above 20%. They have profited from the first quarter-market frenzy, which saw massive trading by ordinary retail investors and frenetic activity on the mergers front. Goldman Sachs enjoyed a 40% yearly jump in its advisory fees.
Consumer-facing and bank stocks have delivered “stellar” earnings, but their stocks have not enjoyed a big boost, says Jon Sindreu in The Wall Street Journal. The KBW Bank index actually fell last week. Investors are starting to fret that the cheap stocks they loaded up on to benefit from economic reopening are the most vulnerable to rising prices. They are now buying “quality” – firms with low debt and cash reserves – instead.
Subscribe to MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE
Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
-
Coventry Building Society bids £780m for Co-operative Bank - what could it mean for customers?
Coventry Building Society has put in an offer of £780 million to buy Co-operative Bank. When will the potential deal happen and what could it mean for customers?
By Vaishali Varu Published
-
Review: Three magnificent Beachcomber resorts in Mauritius
MoneyWeek Travel Ruth Emery explores the Indian Ocean island from Beachcomber resorts Shandrani, Trou aux Biches and Paradis
By Ruth Emery Published
-
The industry at the heart of global technology
The semiconductor industry powers key trends such as artificial intelligence, says Rupert Hargreaves
By Rupert Hargreaves Published
-
Three emerging Asian markets to invest in
Professional investor Chetan Sehgal of Templeton Emerging Markets Investment Trust tells us where he’d put his money
By Chetan Sehgal Published
-
What to consider before investing in small-cap indexes
Small-cap index trackers show why your choice of benchmark can make a large difference to long-term returns
By Cris Sholto Heaton Published
-
Why space investments are the way to go for investors
Space investments will change our world beyond recognition, UK investors should take note
By Merryn Somerset Webb Published
-
Time to tap into Africa’s mobile money boom
Favourable demographics have put Africa on the path to growth when it comes to mobile money and digital banking
By Rupert Hargreaves Published
-
M&S is back in fashion: but how long can this success last?
M&S has exceeded expectations in the past few years, but can it keep up the momentum?
By Rupert Hargreaves Published
-
The end of China’s boom
Like the US, China too got fat on fake money. Now, China's doom is not far away.
By Bill Bonner Published
-
Magic mushrooms — an investment boom or doom?
Investing in these promising medical developments might see you embark on the trip of a lifetime.
By Bruce Packard Published